Construction work set to start on $93 million insulin factory
MANAMA: Construction work for a new insulin factory in Bahrain will soon get underway, it has emerged.
Being built by Gulf Biotech Company at an investment of $93 million, the plant will come up on a 16,000 sqm site in Salman Industrial City, the company's chief executive Dr Riyadh Al Ashban said in a statement yesterday.
"The plant is expected to start operations by mid-2015 with an initial production capacity of 42m units.
"We expect to create around 250 jobs for Bahrainis and Saudis," he said.
The project will be backed by an alliance involving global multinationals Merck, Helm and Linde.
The products will match American and European specifications, he said.
Gulf Biotech's shareholders include Saudi-owned Al Roaya Gulf Group Holdings and the chairman of the company's board is Saudi Prince Sultan bin Fahad bin Abdulaziz.